Disc Medicine, Inc. (IRON)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Research & development$170.6M$96.7M$69.3M$33.4M$25.2M$28.2M
Operating expenses$236.0M$129.7M$91.1M$47.5M$30.9M$34.0M
Operating income−$236.0M−$129.7M−$91.1M−$47.5M−$30.9M−$34.0M
EBITDAderived−$235.7M−$129.6M−$91.0M−$47.4M−$30.9M
Net income−$212.2M−$109.4M−$76.4M−$46.8M−$36.0M−$40.8M
Basic EPSper diluted share-$6.01-$3.96-$3.42-$45.05-$40.95-$2.70
Diluted EPSper diluted share-$6.01-$3.96-$3.42-$45.05-$40.95-$2.70

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)208$163.79M disclosed value
208 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 29, 2026Form 4 · 10b5-1Khara RahulChief Legal OfficerSellCommon Stock1.6K$75.00$123.7K52.2K
Jun 26, 2026Form 4 · 10b5-1Khara RahulChief Legal OfficerSellCommon Stock851$75.00$63.8K52.2K
Jun 26, 2026Form 4 · 10b5-1Yu Jonathan Yen-WenChief Operating OfficerSellCommon Stock300$72.50$21.8K54.3K
Jun 22, 2026Form 4 · 10b5-1Yu Jonathan Yen-WenChief Operating OfficerSellCommon Stock9.7K$72.66$704.8K54.3K
Jun 18, 2026Form 4 · 10b5-1Khara RahulChief Legal OfficerSellCommon Stock500$71.62$35.8K52.2K